Disease | ovarian cancer |
Phenotype | C0028754|obesity |
Sentences | 7 |
PubMedID- 23369448 | The pro-tumorigenic role of leptin on breast, colon, prostate, and ovarian cancer in patients with obesity, mets, and t2dm was recently reviewed [85,113,114]. |
PubMedID- 22927847 | Furthermore, a meta-analysis of ten cohort studies has shown that overweight and obesity are associated with higher ovarian cancer mortality (or, 1.6; 95% ci 1.1–2.34) and that, among patients with advanced ovarian cancer, premorbid obesity is associated with worse prognosis (or, 1.5; 95% ci 1.09–1.93) [149]. |
PubMedID- 24834130 | The association between obesity at the time of diagnosis and ovarian cancer survival was weaker than the association between bmi evaluated before diagnosis and ovarian cancer survival. |
PubMedID- 26053184 | The evidence linking obesity with ovarian cancer remains controversial. |
PubMedID- 24944530 | It is noted that the obesity is associated with ovarian cancer, as well as breast cancer in postmenopausal women. |
PubMedID- 25779915 | obesity increases the risk of endometrial and ovarian cancer, and oestrogen receptor (er)-progesterone receptor (pr)-positive postmenopausal breast cancer. |
PubMedID- 23652833 | Although the literature to date focusing on obesity and prognosis of ovarian cancer has been inconclusive, a recent meta-analysis reported a positive relationship between early adulthood bmi and mortality among patients with ovarian cancer [10]. |
Page: 1